Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-700
Closed -$2.71K 472
2025
Q4
$2.71K Sell
700
-150
-18% -$768 ﹤0.01% 448
2025
Q3
$4.55K Buy
850
+150
+21% +$812 ﹤0.01% 648
2025
Q2
$3.8K Buy
+700
New +$2.78K ﹤0.01% 428

Groupe la Francaise's CVAC Position: Q1 2026 in Review

Groupe la Francaise sold out of CureVac (CVAC) in Q1 2026, closing a stake of 700 shares — an estimated $2.71K sold.

Groupe la Francaise first reported a position in CVAC in Q2 2025 and held it in 3 quarters. The position peaked at $4.55K in Q3 2025. 0 funds tracked by Wall St. Rank hold CVAC as of Q1 2026.

  • Groupe la Francaise reported no remaining CureVac position as of Q1 2026 after selling out during the quarter.
  • Groupe la Francaise sold 700 CureVac shares in Q1 2026, an estimated $2.71K.
  • Groupe la Francaise first reported a position in CureVac in Q2 2025 and held it in 3 quarters.
  • Groupe la Francaise's CureVac position peaked at $4.55K in Q3 2025.
  • 0 funds tracked by Wall St. Rank held CureVac as of Q1 2026.

Based on Groupe la Francaise's 13F filing for Q1 2026, filed 21 May 2026.